Skip to main content

Building

A better future

through education, skill development and research

LEARN MORE

Certain Antibiotics During Pregnancy May Increase Risk of Birth Defects

A new study has found links between certain antibiotics during pregnancy and major congenital malformations in newborns.

Wednesday, July 19, 2017 12:01 am EDT
"Infections during pregnancy are frequent and should be treated; however, our study highlights safer options for the treatment of infections, more specifically urinary tract infections or pulmonary infections, at least during the first trimester of pregnancy"

A new study has found links between certain antibiotics during pregnancy and major congenital malformations in newborns.

The study included an analysis of information on 139,938 live births in Quebec, Canada, between 1998 and 2008. Clindamycin, doxycycline, quinolones, macrolides, and phenoxymethylpenicillin were linked to organ-specific malformations. Amoxicillin, cephalosporins, and nitrofurantoin were not associated with birth defects.

Although the absolute risks for birth defects were small, physicians should consider prescribing other antibiotics when treating patients with infections during pregnancy.

“Infections during pregnancy are frequent and should be treated; however, our study highlights safer options for the treatment of infections, more specifically urinary tract infections or pulmonary infections, at least during the first trimester of pregnancy,” said Dr. Anick Bérard, senior author of the British Journal of Clinical Pharmacology study.

Additional Information

Link to Studyhttp://onlinelibrary.wiley.com/doi/10.1111/bcp.13364/full

About Journal

The British Journal of Clinical Pharmacology (BJCP) contains papers and reports on all aspects of drug action in humans: invited review articles, original papers and correspondence. The journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry.

Multimedia Files:

Preview image

Contact:

Penny Smith
+44 (0)1243 770448
sciencenewsroom@wiley.com

Business Wire NewsHQsm